Asante Bio

Asante Bio, founded in 2018 and based in Cambridge, USA, is a private, pre-revenue biotechnology company pioneering regenerative orthobiologic implants. Its core innovation lies in additive biomanufacturing platforms that process natural biopolymers into high-strength, disruptive medical devices designed for joint preservation. The company targets high-growth orthopedic indications with a strategy anchored in proprietary biomaterials, domestic manufacturing, and collaboration with a world-class surgeon-developer faculty to revolutionize value-based care.

Proprietary additive biomanufacturing platform using electrospinning and other techniques to process natural biopolymers and extracellular matrix components into high-strength, 3D regenerative orthobiologic implants with tailored mechanical and biological properties.

Asante competes in the orthobiologics and sports medicine device space, which includes large medtech companies (e.g., Smith & Nephew, Stryker, Zimmer Biomet) with extensive portfolios and numerous smaller, innovative startups. Differentiation hinges on proving the unique mechanical and regenerative benefits of its additively manufactured biopolymer implants.